Mackenzie Financial
ADMA icon

Mackenzie Financial’s ADMA Biologics ADMA Stock Holding History

Mackenzie Financial’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,526
Closed -$266K – 1430
2025
Q4 		$266K Sell
14,526
-319
-2% -$5.38K ﹤0.01% 1430
2025
Q3 		$218K Sell
14,845
-3,234
-18% -$55.4K ﹤0.01% 1529
2025
Q2 		$329K Sell
18,079
-50,594
-74% -$1.03M ﹤0.01% 1361
2025
Q1 		$1.36M Sell
68,673
-5,866
-8% -$101K ﹤0.01% 892
2024
Q4 		$1.28M Buy
74,539
+50,660
+212% +$953K ﹤0.01% 884
2024
Q3 		$477K Buy
23,879
+1,190
+5% +$18.5K ﹤0.01% 1034
2024
Q2 		$254K Buy
22,689
+507
+2% +$4.25K ﹤0.01% 1244
2024
Q1 		$146K Buy
22,182
+1,380
+7% +$7.54K ﹤0.01% 1389
2023
Q4 		$94K Hold
20,802
– – ﹤0.01% 1415
2023
Q3 		$69.3K Hold
20,802
– – ﹤0.01% 1384
2023
Q2 		$76.3K Buy
20,802
+8,567
+70% +$31.8K ﹤0.01% 1427
2023
Q1 		$40.5K Buy
12,235
+700
+6% +$2.42K ﹤0.01% 1453
2022
Q4 		$44.8K Sell
11,535
-700
-6% -$2.16K ﹤0.01% 1357
2022
Q3 		$30K Sell
12,235
-518
-4% -$1.24K ﹤0.01% 1391
2022
Q2 		$258K Buy
+12,753
New +$25.1K ﹤0.01% 1160

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Mackenzie Financial's ADMA Position: Q1 2026 in Review

Mackenzie Financial sold out of ADMA Biologics (ADMA) in Q1 2026, closing a stake of 14,526 shares — an estimated $266K sold.

Mackenzie Financial first reported a position in ADMA in Q2 2022 and held it in 15 quarters. The position peaked at $1.36M in Q1 2025. 357 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Mackenzie Financial reported no remaining ADMA Biologics position as of Q1 2026 after selling out during the quarter.
  • Mackenzie Financial sold 14,526 ADMA Biologics shares in Q1 2026, an estimated $266K.
  • Mackenzie Financial first reported a position in ADMA Biologics in Q2 2022 and held it in 15 quarters.
  • Mackenzie Financial's ADMA Biologics position peaked at $1.36M in Q1 2025.
  • 357 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.